We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

84 hedge funds and large institutions have $173M invested in ChemoCentryx, Inc. in 2017 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 30 increasing their positions, 26 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

15% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 26

9% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 11

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% less capital invested

Capital invested by funds: $173M → $173M (-$179K)

6% less funds holding

Funds holding: 8984 (-5)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $89K

Holders
84
Holders Change
-5
Holders Change %
-5.62%
% of All Funds
2.09%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
12
Increased
30
Reduced
26
Closed
11
Calls
Puts
$89K
Net Calls
-$89K
Net Calls Change
-$140K
Name Holding Trade Value Shares
Change
Change in
Stake
BI
1
BVF Inc
California
$58.2M +$1.38M +192,000 +2%
BlackRock
2
BlackRock
New York
$15.7M +$15.4M +2,139,920 +13,873%
Franklin Resources
3
Franklin Resources
California
$15.5M
WA
4
Wasatch Advisors
Utah
$14.9M -$2.75M -382,533 -16%
Vanguard Group
5
Vanguard Group
Pennsylvania
$8.73M +$342K +47,475 +4%
Acadian Asset Management
6
Acadian Asset Management
Massachusetts
$6.22M +$2.9M +402,909 +89%
Renaissance Technologies
7
Renaissance Technologies
New York
$4.49M +$1.05M +146,000 +31%
NCM
8
Nantahala Capital Management
Connecticut
$4.41M +$993K +137,898 +29%
AG
9
Artal Group
Luxembourg
$3.98M
State Street
10
State Street
Massachusetts
$2.92M -$11.5K -1,600 -0.4%
SCM
11
Sio Capital Management
New York
$2.14M -$224K -31,100 -10%
D.E. Shaw & Co
12
D.E. Shaw & Co
New York
$1.92M -$573K -79,604 -23%
Northern Trust
13
Northern Trust
Illinois
$1.84M +$41.8K +5,808 +2%
IHM
14
Iguana Healthcare Management
New York
$1.82M -$144K -20,000 -7%
Invesco
15
Invesco
Georgia
$1.78M +$1.92K +266 +0.1%
OAM
16
Oxford Asset Management
United Kingdom
$1.57M -$464K -64,466 -23%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.43M +$62.6K +8,697 +5%
Deutsche Bank
18
Deutsche Bank
Germany
$1.43M +$43.7K +6,067 +3%
AllianceBernstein
19
AllianceBernstein
Tennessee
$1.31M -$1.65M -229,553 -56%
PAWC
20
P.A.W. Capital
Connecticut
$1.17M +$288K +40,000 +33%
PAM
21
Panagora Asset Management
Massachusetts
$1.12M +$767K +106,554 +225%
Millennium Management
22
Millennium Management
New York
$1.12M +$777K +107,890 +238%
SIM
23
Spark Investment Management
New York
$1.05M +$1.04M +144,300 New
TCIM
24
TIAA CREF Investment Management
New York
$936K +$252K +35,049 +37%
Morgan Stanley
25
Morgan Stanley
New York
$896K +$88.6K +12,310 +11%

CCXI Hedge Fund Activity: Q1 2017 in Review

84 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q1 2017, worth a combined $173M — down 0.1% from $173M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CCXI positions and 11 closed out — a net gain of 1 holder — while 30 added to existing stakes and 26 trimmed.

The largest buyer was BlackRock, adding an estimated $15.4M. The largest seller was Wasatch Advisors, cutting an estimated $2.75M.

  • 84 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q1 2017, down from 89 in Q4 2016.
  • Funds reported $173M of ChemoCentryx, Inc. stock for Q1 2017, down 0.1% quarter-over-quarter.
  • 12 funds opened new ChemoCentryx, Inc. positions in Q1 2017 and 11 closed out, a net change of +1 holder.
  • The largest ChemoCentryx, Inc. buyer in Q1 2017 was BlackRock, an estimated $15.4M added.
  • The largest ChemoCentryx, Inc. seller in Q1 2017 was Wasatch Advisors, an estimated $2.75M sold.

Based on aggregated 13F filings for Q1 2017.